NDC 0310-3040

SAPHNELO

Anifrolumab

SAPHNELO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Anifrolumab.

• Product ID: 0310-3040_1585fae3-a657-45e9-907a-e43e69798ef4
• NDC: 0310-3040
• Product Type: Human Prescription Drug
• Proprietary Name: SAPHNELO
• Generic Name: Anifrolumab
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-07-30
• Marketing Category: BLA /
• Application Number: BLA761123
• Labeler Name: AstraZeneca Pharmaceuticals LP
• Substance Name: ANIFROLUMAB
• Active Ingredient Strength: 300 mg/2mL
• Pharm Classes: Type I Interferon Receptor Antagonist [EPC], Type I Interferon Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0310-3040-00

1 VIAL, GLASS in 1 CARTON (0310-3040-00) > 2 mL in 1 VIAL, GLASS

• Marketing Start Date: 2021-07-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details